BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 700980)

  • 1. Biochemical markers in breast carcinoma.
    Duffy MJ; Hynes N; Groarke Y; Oliver J; O'Broin A; Duffy G
    Ir Med J; 1978 Sep; 71(12):408-13. PubMed ID: 700980
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of biochemical markers in breast cancer.
    Coombes RC; Powles TJ; Neville AM
    Proc R Soc Med; 1977 Dec; 70(12):843-5. PubMed ID: 601063
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic markers and breast cancer.
    Waalkes TP; Tormey DC
    Semin Oncol; 1978 Dec; 5(4):434-44. PubMed ID: 83677
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor associated markers in breast cancer.
    Franchimont P; Zangerle PF; Colin C; Osterrieth P; Hendrick JC; van Cauwenberge JR; Hustin J
    Eur J Cancer (1965); 1980; Suppl 1():17-20. PubMed ID: 6172278
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
    Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
    Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of carcinoembryonic antigen determinations in the evaluation and surveillance of breast cancers].
    Pico JL; Henry R; Mériadec B; Salard JL
    Bull Cancer; 1976; 63(4):595-606. PubMed ID: 1021187
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of carcinoembryonic antigen test in human mammary carcinoma.
    Batabyal SK; Ghosh SN; Roy NK; Mehrotra YN; Gupta A
    Indian J Pathol Microbiol; 1987 Oct; 30(4):407-12. PubMed ID: 3507401
    [No Abstract]   [Full Text] [Related]  

  • 8. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers as prognostic and clinical evaluation tools.
    Tormey DC; Waalkes TP
    Eur J Cancer (1965); 1980; Suppl 1():21-4. PubMed ID: 7032933
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
    Arora B; Chhabra A; Yadav MS; Arora DR
    Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative operating characteristic analysis and group modeling for tumor markers: comparison of CA 15.3, carcinoembryonic antigen, and mucin-like carcinoma-associated antigen in breast carcinoma.
    Silver HK; Archibald BL; Ragaz J; Coldman AJ
    Cancer Res; 1991 Apr; 51(7):1904-9. PubMed ID: 2004374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear medicine procedures in obstetrics and gynecology.
    Gorten RJ
    Radiol Clin North Am; 1974 Apr; 12(1):147-65. PubMed ID: 4820825
    [No Abstract]   [Full Text] [Related]  

  • 13. The significance of tumor marker assay in the staging of breast cancer. Assessment of ferritin and beta-HCG levels.
    Micali B; Gioffrè Florio MA; Venuti A; Giorgianni G; Saitta FP
    J Nucl Med Allied Sci; 1981; 25(3):65-70. PubMed ID: 7310528
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
    Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F
    Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of ferritin, CEA and AFP in patients operated on for carcinoma of the breast. Preliminary results].
    Latteri M; Spinnato G; Pantuso G; Di Lisi G; Latteri S; Bellanca L; Latteri MT; Cirello B; Ciaccio M
    Minerva Chir; 1987 May; 42(10):911-6. PubMed ID: 2442669
    [No Abstract]   [Full Text] [Related]  

  • 16. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical detection of recurrent breast cancer.
    Smith RE
    Cancer Detect Prev; 1988; 11(3-6):303-9. PubMed ID: 3292045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucoid carcinoma antigen--a new tumor marker].
    Bieglmayer C; Szepesi T; Neunteufel W
    Gynakol Rundsch; 1988; 28 Suppl 2():203-5. PubMed ID: 3234919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor markers in breast cancer].
    Polevaia EB; Tkacheva GA; Letiagin VP; Ivanov VM; Koposova TL
    Sov Med; 1985; (3):25-9. PubMed ID: 4023831
    [No Abstract]   [Full Text] [Related]  

  • 20. A biochemical approach to the staging of human breast cancer.
    Coombes RC; Powles TJ; Gazet JC; Ford HT; Nash AG; Sloane JP; Hillyard CJ; Thomas P; Keyser JW; Marcus D; Zinberg N; Stimson WH; Neville AM
    Cancer; 1977 Aug; 40(2):937-44. PubMed ID: 890676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.